Young Americans' Marijuana Use Increases with Legalization: Survey

Nov.29.2022
Young Americans' Marijuana Use Increases with Legalization: Survey
Legalization of marijuana in the US has led to a significant increase in young adults smoking, according to a new survey.

A recent survey conducted in the United States has revealed a sharp increase in the number of young people consuming marijuana, following its legalization in many parts of the country, including New York.


A Gallup Poll analysis has revealed that 26% of individuals aged 18 to 29 have used marijuana, compared to 17% in 2015.


According to a Gallup report, smoking rates among young people have dropped from 35% in 2003 to 25% a decade ago, and now stand at 12%, which is more than two times lower than before.


According to an analysis by Gallup, smoking rates have dramatically declined in the past 20 years, driven mainly by a decrease in smoking among young people, which is encouraging for public health officials. However, more young people are turning to marijuana, possibly due to its legalization in more states and its prevalence among youth compared to traditional smoking, along with the use of e-cigarettes.


Twenty-one states have legalized the recreational use of marijuana, including several populous states on the East and West Coasts. Other states, such as Florida and Pennsylvania, have legalized marijuana for medicinal purposes.


According to Gallup's analysis, it supports a recent study published in the journal "Addictive Behaviors" by Temple University researchers. The study claims that "after the legalization of recreational marijuana use, the monthly usage rate among adolescents and young adults increased." The researchers warned that there will be an increase in marijuana addiction or untreated "marijuana use disorders.


The study also found that "among young adults, higher rates of marijuana use were associated with lower rates of hospitalization for CUD treatment.


Opponents of marijuana legalization say that their concerns are now in the past.


Due to coordinated preventative efforts, marijuana usage has steadily decreased for several decades. However, the legalization and commercialization of marijuana are now threatening to undo these public health benefits. "Smart Approaches to Marijuana" President Kevin Sabet stated, "We also cannot ignore the fact that young people are starting to use new forms of marijuana, such as e-cigarettes and concentrated products, which are closely linked to severe mental health risks and higher rates of addiction.


However, supporters say that they are pleased that people can use it legally.


I am delighted to be a part of this process. I am passionate about changing the stigma around cannabis. There is a certain stigma, but culture is changing," said Nicholas Koury, who last week received one of the first licenses issued by the state of New York to open a cannabis dispensary in Manhattan. "The stigma is not necessarily accurate. Cannabis can help people's mental state and has medicinal value," he said.


According to a survey, 26% of people aged 18 to 29 have admitted to using marijuana, which is higher than the reported 17% in 2015.


Last week, New York issued its first round of 28 cannabis dispensary licenses and is now tackling a rapidly growing unlicensed and unregulated black market where Budagges and other top shops openly sell marijuana and cannabis edibles.


According to a Gallup survey, some young smokers appear to be turning to e-cigarettes or less toxic electronic cigarettes, with approximately 7% of US adults reporting using them in the past week.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Swedish Match Faces Broader Labeling Order After ZYN Inspection, Documents Obtained by 2Firsts Show
Swedish Match Faces Broader Labeling Order After ZYN Inspection, Documents Obtained by 2Firsts Show
Documents obtained by 2Firsts show that Sweden's Public Health Agency ordered Swedish Match to revise ingredient labels beyond the five ZYN products inspected. The dispute centers on whether flavoring ingredients must be individually disclosed, with Swedish Match citing trade-secret protection and the regulator insisting on full ingredient disclosure. The company faces a conditional penalty of SEK 2 million per month for noncompliance. As of October 22, the agency had received no appeal, despite the company's stated intention to challenge the decision.
Oct.22
Arizona Turns to a 50% Retail Vape Tax as Tobacco Tax Revenue Falls 47% From 2008
Arizona Turns to a 50% Retail Vape Tax as Tobacco Tax Revenue Falls 47% From 2008
Arizona's First Things First is pushing for an excise tax equal to 50% of the retail price of vaping products, estimating that the measure could generate about $100 million annually. The agency says its tobacco-tax revenue has fallen 47% from 2008 levels. Arizona has attempted to broaden its nicotine tax base in each of the past two years: a 2025 bill proposed a 50% wholesale-price tax, while a 2026 measure shifted to a 50% retail-price tax covering alternative nicotine products and vapor products. Separately, the state enacted HB 4001 this year to establish a new licensing and sales framework for alternative nicotine products.
Sep.21
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Philip Morris Japan (PMJ) launched the IQOS ILUMA i PRIME Ginza Limited Model Set in Tokyo on September 4, 2026, alongside the opening of IQOS Flagship Ginza, the brand’s first global flagship store. The Oasis Blue edition is limited to 1,814 individually numbered units, with the figure derived from the store’s address at Ginza 1-8-14. The set also includes two Yamanaka-nuri glasses and special packaging, priced at JPY 11,980 and sold exclusively at the Ginza flagship.
Sep.07
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11